ClinicalTrials.gov
public full text
Public Domain
Serum BDNF Role as a Biomarker for Stroke Rehabilitation
This study aims to develop the quantitative biomarker to establish the individualized strategy in stroke rehabilitation. Brain-derived neurotrophic factor (BDNF) acts on certain neurons of the central nervous system (CNS) helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses. BDNF in CNS can be assessed by analysing serum BDNF. The final objective of this study is to demonstrate a role of biomarker of BDNF in stroke rehabilitation to establish the individualized strategy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis#850391
- The Screening of Neuroprotective Biomarkers After Acute Ischemic Stroke#806349
- The Natural History of Traumatic Spinal Cord Injury Using fMRI, MRS and DTI#1046418
- Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.#858464
- Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh#1397253
Record · ID 1453328
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive